Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kinzig

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|May 9, 2007
Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteersJ B Bulitta, S B Duffull, M Kinzig-Schippers, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteersC K Naber, M Steghafner, M Kinzig-Schippers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patientsR Nau, M Kinzig-Schippers, F Sörgel, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I studyG García-Calvo, A Parra, L Aguilar, et al.
Infection|March 1, 1997
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral doseH Hofbauer, K G Naber, M Kinzig-Schippers, et al.
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin in patients with liver impairmentG R Granneman, G Mahr, C Locke, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
Antimicrobial Agents and Chemotherapy|January 13, 2010
Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteersJ B Bulitta, C B Landersdorfer, S J Hüttner, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patientsF Kanefendt, A Lindauer, M Kinzig, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2008
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracisA Louie, H S Heine, K Kim, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|May 9, 2007
Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteersJ B Bulitta, S B Duffull, M Kinzig-Schippers, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteersC K Naber, M Steghafner, M Kinzig-Schippers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patientsR Nau, M Kinzig-Schippers, F Sörgel, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I studyG García-Calvo, A Parra, L Aguilar, et al.
Infection|March 1, 1997
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral doseH Hofbauer, K G Naber, M Kinzig-Schippers, et al.
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin in patients with liver impairmentG R Granneman, G Mahr, C Locke, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
Antimicrobial Agents and Chemotherapy|January 13, 2010
Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteersJ B Bulitta, C B Landersdorfer, S J Hüttner, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patientsF Kanefendt, A Lindauer, M Kinzig, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2008
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracisA Louie, H S Heine, K Kim, et al.
Pageof 7